Pulmonary Function Testing Systems Market 2019 Fortune Business Insights report provides information regarding market size, share, trends, growth, cost structure, capacity, and revenue and forecast 2026

According to the report, titled, “Pulmonary Function Testing Systems Market Size, Share and Global Trend by System Type (Complete PFT Systems, Portable PFT Systems), By Test Type (Spirometry, Gas Exchange Testing, High Altitude Simulation Testing, Others), By Component (Hardware, Software), By End User (Hospitals and Clinics, Diagnostic Centers) and Geography Forecast till 2026,” the market is categorized on the basis of system type, test type, component, end-user, and geography. Amongthese segments, the portable pulmonary function testing system segment is anticipated to lead the market, based on system type. This is attributable to the easy-use and better ergonomics facility of these system types.

Browse Complete Report [email protected]

A strategic partnership was agreed upon by Mayo Clinic and the Association of Breath Diagnostics in March 2019 for designing and developing a new system. This new system will detect and analyze lung cancer by taking the exhaled breath of the patient as a test sample. These types of pulmonary testing devices are used for measuring the functioning and capacity of the lungs along with gas exchange, rate of breath flow, lung volume, and other aspects. Such advancements in the medical technology is likely to bode well for the global pulmonary function testing systems market, says Fortune Business Insights in their recent report.

Some of the companies operating in the global pulmonary function testing system market are mentioned below:

  • Thorasys
  • COSMED Srl
  • Medisoft Group
  • Medical equipment Europe GmbH
  • Ganshorn Medicine Electronic
  • MGC Diagnostics Corporation
  • BD

Get Sample PDF [email protected]

The report focuses on various fators impacting the market’s growth trajectory. It covers strategies adopted by various leading players. It also examines the impact of these strategies on the overall market. Information included in this report is obtained from trusted resources. Furthermore, primary and secondary research methods are used to study the market’s trajectory over the forecast period.

Key Segmentation:

By System Type

  • Complete PFT Systems
  • Portable PFT Systems

By Test Type

  • Spirometry
  • Gas Exchange Testing
  • High Altitude Simulation Testing
  • Others

By Component

  • Hardware
  • Software

By End User

  • Hospitals and Clinics
  • Diagnostic Centers
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East and Africa (South Africa, GCC and Rest of Middle East and Africa)

Increasing Awareness about Pulmonary Diseases to Help Market Show Rapid Growth in Asia Pacific

In 2016, a study conducted the American Academy of Allergy, Asthma, and Immunology estimated about 8.3% of children of the total population in the U.S. suffer from asthma. The rising prevalence of lungs and breathing disorders are anticipated to help North America generate huge revenue to the market. This is likely to remain the same in the forthcoming years on account of the presence of better healthcare infrastructure and medical facilities in its developed nations.

On the other side, Asia Pacific is expected to offer lucrative growth opportunities in the forecast period owing to the increasing investments in the expansion of healthcare infrastructure and the discovery of technological advancement for various diagnostic procedures. In addition to this, the rising awareness about pulmonary problems and the availability of treatment options is likely to help this region grow at a faster rate in the future.

Increasing Investment inMedical Robots For Detection Of Lung Disorders to Favor Market Growth

Over the past couple of years, market vendors of pulmonary testing systems had successfully implemented various strategies that have helped expand their business, subsequently bolstering growth witnessed in the market. Some of these innovations include:

A U.K. based company namely Owlstone Medical invested a considerate amount of money in the designing and development of cancer breathalyzer test in January 2018. They also tried to develop new devices for idiopathic pulmonary fibrosis patients.

To increase the sale of their newly developed pulmonary function testing medical robot, Auris Health increased its investments in November 2018. This is anticipated to generate greater revenue in the near future.

More Trending Topics from Fortune Business Insights:

At 17.7% CAGR of Clear Aligners Market | US$ 8.2 Bn Forecast by 2026

Breast Implants Market 2019 Size, Industry Outlook, Insights, Growth, Trends, Share and Forecast 2026

Surgical Robots Market 2019: Technological Strategies, Business Advancements and Top-Vendor Landscape Forecast by 2026

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Pulmonary Function Testing Systems Market 2019-Global Industry Trends, Share, Growth Insight, Size, Forecast till 2026